Skip to main content

Cyteir Therapeutics, Inc.

CYTDelisted Mar 18, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001662244

Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Cyteir Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of CYT: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders033+33
Shares016.6M+16.6M
Value$0$352.6M+$352.6M

New holders (33)

Institutions that held Cyteir Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CYT in Q2 2021
InstitutionSharesValue% of portfolio
Novo Holdings A/S4,840,413$103.6M4.59%
Ra Capital Management, L.P.3,247,117$69.5M1.12%
Avidity Partners Management LP1,808,394$38.7M1.05%
Janus Henderson Group PLC1,889,833$37.9M0.02%
FMR LLC1,060,206$22.7M0.00%
Baker Bros. Advisors LP812,640$17.4M0.08%
Ally Bridge Group (NY) LLC626,843$13.4M3.76%
Caas Capital Management LP500,000$10.7M0.57%
Acuta Capital Partners, LLC277,777$5.94M2.55%
Sofinnova Investments, Inc.265,000$5.67M0.34%
Suvretta Capital Management, LLC175,000$3.75M0.06%
Monashee Investment Management LLC145,000$3.10M0.37%
Millennium Management LLC138,165$2.96M0.00%
Sphera Funds Management Ltd.125,000$2.67M0.25%
HealthCor Management, L.P.120,000$2.57M0.11%
Alliancebernstein L.P.110,000$2.35M0.00%
Norges Bank110,000$2.35M0.00%
Marshall Wace North America L.P.90,258$1.93M0.01%
Vanguard Group Inc70,000$1.50M0.00%
Goldman Sachs Group Inc62,069$1.33M0.00%
LMR Partners LLP36,999$792.0K0.01%
Ghisallo Capital Management LLC25,000$535.0K0.02%
Geode Capital Management, LLC16,280$348.0K0.00%
Qube Research & Technologies Ltd16,168$346.0K0.00%
ExodusPoint Capital Management, LP11,385$244.0K0.00%
Maven Securities LTD10,870$217.0K0.02%
Pinz Capital Management, LP1,000$21.0K0.01%
AlphaCentric Advisors LLC1,000$21.0K0.01%
UBS Group AG450$10.0K0.00%
Royal Bank of Canada295$6.00K0.00%
ACT Capital Management, LLC90$2.00K0.00%
Morgan Stanley70$1.00K0.00%
Bank of America Corp10$00.00%

Sold out (0)

Institutions that held Cyteir Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

None.